induced behavioral sensitization by inhibition of brain nitric
oxide synthase. J. Pharmacol. Exp. Ther. 282:521–527; 1997.
16. Itzhak, Y.; Gandia, C.; Huang, P. L.; Ali, S. F.: Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamineinduced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 30.
284:1040–1047; 1998.
17. Itzhak, Y.; Martin, J. L.; Ali, S. F.; Norenberg, M. D.: Depletion
of striatal dopamine transporter does not affect psychostimulantinduced locomotor activity. Neuroreport 8:3245–3249; 1997.
18. Izenwasser, S.; Werling, L. L.; Cox, B. M.: Comparison of the 31.
effects of cocaine and other inhibitors of dopamine uptake in rat
striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res. 520:303–309; 1990.
19. Joyce, E.; Koob, G. F.: Amphetamine-, scopolamine-, and caf- 32.
feine-induced locomotor activity following 6-hydroxydopamine
lesions of mesolimbic dopamine system. Psychopharmacology
(Berlin) 73:311–313; 1981. 33.
20. Kalivas, P. W.; Stewart, J.: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of
motor activity. Brain Res. Rev. 16:223–244; 1991. 34.
21. Kelly, P. H.; Iversen, S. D.: Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulants-induced locomotor activity in rats. Eur. J. Pharmacol. 40:45–
56; 1976. 35.
22. Koob, G. F.: Neuronal mechanisms of drug reinforcement. Ann.
NY Acad. Sci. 654:171–191; 1992.
23. Kuhar, M. J.; Ritz, M. C.;Boja, J. W.: The dopamine hypothesis in 36.
the reinforcing properties of cocaine. Trends Neurosci. 14:299–
302; 1991.
24. Langston, J. W.; Ballard, P.; Tetrude, J. W.; Irwin, I.: Chronic parkinsonism in humans due to product of meperidine-analog syn- 37.
thesis. Science 219:979–980; 1983.
25. Malison, R. T.; Best, S. E.; van Dyck, C. H.; McCanc, E. F.; Wallace, E. A.; Laurelle, M.; Baldwin, R. M.; Seibyl, J. P.; Price, L. H.;
Kosten, T. R.; Innis, R. B.: Elevated striatal dopamine trans- 38.
porter during acute cocaine abstinence as measured by [125I]βCIT SPECT. Am. J. Psychiatry 155:832–834; 1998.
26. Morissette, M.; Goulet, M.; Calon, F.; Falardeau, P.; Blanchet, P. J.;
Bedard, P.; Di Paolo, T.: Changes in D1 and D2 dopamine recep- 39.
tor mRNA in the brain of monkeys lesioned with MPTP: Correction
with chronic administration of L-3,4-dihydroxyphenylalanine. J. 40.
Pharmacol. Exp. Ther. 50:1073–1079; 1996.
27. Pierce, R. C.; Kalivas, P. W.: A circuitry model of the expression
of behavioral sensitization to amphetamine-like psychostimu- 41.
lants. Brain Res. Rev. 25:192–216; 1997.
28. Pilotte, N. S.; Sharp, L. G.; Kuhar, M. J.: Withdrawal from
repeated intravenous infusions of cocaine persistently reduces
binding to dopamine transporters in the nucleus accumbens of
Lewis rats. J. Pharmacol. Exp. Ther. 269:963–969; 1994. 42.
Post, R. M.; Weiss, S. R.; Pert, A.: Cocaine-induced behavioral
sensitization and kindling: Implications for the emergence of psy-
